Your browser doesn't support javascript.
loading
Tezepelumab normalizes serum interleukin-5 and -13 levels in patients with severe, uncontrolled asthma.
Pham, Tuyet-Hang; Chen, Claudia; Colice, Gene; Parnes, Jane R; Griffiths, Janet M; Cook, Bill.
Affiliation
  • Pham TH; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland. Electronic address: tuyet-hang.pham@astrazeneca.com.
  • Chen C; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
  • Colice G; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
  • Parnes JR; Translational Medicine, Amgen, Thousand Oaks, California.
  • Griffiths JM; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
  • Cook B; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland.
Ann Allergy Asthma Immunol ; 127(6): 689-691, 2021 12.
Article in En | MEDLINE | ID: mdl-34403803
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Interleukin-5 / Interleukin-13 / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Humans Language: En Journal: Ann Allergy Asthma Immunol Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Interleukin-5 / Interleukin-13 / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Humans Language: En Journal: Ann Allergy Asthma Immunol Year: 2021 Document type: Article